Loading
Total declarations
Companies
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jan 2012 for Pharmasset Inc, €2.4M.
Insider track record
Disclosed buys
13
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
13
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael K. Inouye: trading record in brief
Michael K. Inouye is a declared insider at 2 companies; the most frequent names are Pharmasset Inc and Pharmacyclics Inc. Over a trading history stretching from 21 August 2007 to 12 January 2012, the count stands at 20 filings.
Every open-market trade on record is a purchase: 13 purchases worth €51k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 6 share grants.
In size, the median ticket on the buying side is €1,595.
The record was last updated on 17 January 2012 with a transaction (€2.4M) in Pharmasset Inc. The latest purchase dates back some time: it was published 6,444 days ago, on 2 March 2009. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael K. Inouye
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
22,000 shares@ US$137.00Common StockSEC:0001209191-12-003894:0
1,000 shares0Common Stock, $.001 par value per shareSEC:0001209191-11-051682:0
2,000 shares0Common Stock, $.001 par value per shareSEC:0001192482-11-000089:0
2,000 shares0Common Stock, $.001 par value per shareSEC:0001192482-10-000072:0
2,000 shares0Common Stock, $.001 par value per shareSEC:0001192482-09-000071:0
100 shares@ US$10.59Common Stock, $.001 par value per shareSEC:0001192482-09-000026:0
Canonical exit: 27 May 2009 (T+90)
131 shares@ US$10.60Common Stock, $.001 par value per shareSEC:0001192482-09-000026:1
Canonical exit: 27 May 2009 (T+90)
300 shares@ US$10.63Common Stock, $.001 par value per shareSEC:0001192482-09-000026:2
Canonical exit: 27 May 2009 (T+90)
300 shares@ US$10.65Common Stock, $.001 par value per shareSEC:0001192482-09-000026:3
Canonical exit: 27 May 2009 (T+90)
200 shares@ US$10.64Common Stock, $.001 par value per shareSEC:0001192482-09-000026:4
Canonical exit: 27 May 2009 (T+90)
100 shares@ US$10.67Common Stock, $.001 par value per shareSEC:0001192482-09-000026:5
Canonical exit: 27 May 2009 (T+90)
119 shares@ US$10.68Common Stock, $.001 par value per shareSEC:0001192482-09-000026:6
Canonical exit: 27 May 2009 (T+90)
500 shares@ US$10.11Common Stock, $.001 par value per shareSEC:0001192482-09-000026:7
Canonical exit: 28 May 2009 (T+90)
58 shares@ US$10.07Common Stock, $.001 par value per shareSEC:0001192482-09-000026:8
Canonical exit: 28 May 2009 (T+90)
300 shares@ US$10.09Common Stock, $.001 par value per shareSEC:0001192482-09-000026:9
Canonical exit: 28 May 2009 (T+90)
192 shares@ US$10.10Common Stock, $.001 par value per shareSEC:0001192482-09-000026:10
Canonical exit: 28 May 2009 (T+90)
200 shares@ US$10.11Common Stock, $.001 par value per shareSEC:0001192482-09-000026:11
Canonical exit: 28 May 2009 (T+90)
2,000 shares0Common Stock, $.001 par value per shareSEC:0001192482-08-000331:0
2,000 shares0Common Stock, $.01 par value per shareSEC:0001192482-08-000324:0
20,000 shares@ US$2.04Common StockSEC:0001209191-07-049972:0
Canonical exit: 19 Nov 2007 (T+90)
20 of 20 declarations
